# Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty

> **NCT02323373** · PHASE2 · COMPLETED · sponsor: **Irmandade da Santa Casa de Misericordia de Sao Paulo** · enrollment: 90 (actual)

## Conditions studied

- Arthrosis

## Interventions

- **DRUG:** Tranexamic Acid - topical
- **DRUG:** Placebo
- **DRUG:** Tranexamic Acid - intravenous

## Key facts

- **NCT ID:** NCT02323373
- **Lead sponsor:** Irmandade da Santa Casa de Misericordia de Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323373, "Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02323373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*